pharmacodynamic pharmacokinetic study oral curcuma extract patients colorectal cancer pubmed ncbi abstract curcuma spp extracts dietary polyphenol curcumin prevent colon cancer rodents view sparse information pharmacodynamics pharmacokinetics curcumin humans dose-escalation pilot study standardized curcuma extract proprietary capsule form performed doses num num mg/day num mg curcumin fifteen patients advanced colorectal cancer refractory standard chemotherapies received curcuma extract daily num months activity glutathione s-transferase levels dna adduct num formed malondialdehyde product lipid peroxidation prostaglandin biosynthesis measured patients blood cells oral curcuma extract tolerated dose-limiting toxicity observed curcumin metabolites detected blood urine curcumin recovered feces curcumin sulfate identified feces patient ingestion num mg curcuma extract num days accompanied num decrease lymphocytic glutathione s-transferase activity higher dose levels effect observed leukocytic num levels constant patient unaffected treatment radiologically stable disease demonstrated patients num months treatment results suggest curcuma extract administered safely patients doses num daily equivalent num mg curcumin curcumin low oral bioavailability humans undergo intestinal metabolism larger clinical trials curcuma extract merited 
